Vertebroplasty: A promising but as yet unproven intervention for painful osteoporotic spinal fractures

Medical Journal of Australia

Volumn 185, Issue 7, 2006, Pages 351-352

  Buchbinder, Rachelle ^a   Osborne, Richard H ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ROFECOXIB;

ADVISORY COMMITTEE; BONE PAIN; COST EFFECTIVENESS ANALYSIS; EDITORIAL; EVIDENCE BASED MEDICINE; FRAGILITY FRACTURE; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEART INFARCTION; HUMAN; MEDICAL RESEARCH; OSTEOPOROSIS; PERCUTANEOUS VERTEBROPLASTY; PUBLICATION; REIMBURSEMENT; RISK BENEFIT ANALYSIS; SPINE FRACTURE; STROKE; THERAPY EFFECT;

EID: 33749618162     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00607.x     Document Type: Editorial

References (14)

1. Caldwell BS, Aldington S, Weatherall M, et al. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006; 99: 132-140.
2. Medical Services Advisory Committee. Minutes of meeting no. 31 - 24 August 2005 - Brisbane. http://www.msac.gov.au/internet/msac/ publishing.nsf/Content/2005-aug-1 (accessed Aug 2006).
3. Hollingworth W, Jarvik JG. Evidence on the effectiveness and cost-effectiveness of vertebroplasty: a review of policy makers' responses. Acad Radiol 2006; 13: 550-555.
4. Jarvik J, Deyo R. Cementing the evidence: time for a randomized trial of vertebroplasty. AJNR Am J Neuroradiol 2000; 21: 1373-1374.
5. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 2002; 136: 471-476.
6. Álvarez L, Alcaraz M, Pérez-Higueras A, et al. Percutaneous vertebroplasty: functional improvement in patients with osteoporotic compression fractures. Spine 2006; 31: 1113-1118.
7. Diamond TH, Bryant C, Browne L, Clark WA. Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust 2006; 184: 113-117.
8. National Health and Medical Research Council. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. 2005. http://www.nhmrc.gov.au/publications/_files/levels_grades05.pdf (accessed Aug 2006).
9. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
10. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001; 285: 320-323.
11. Ha KY, Lee JS, Kim KW, Chon JS. Percutaneous vertebroplasty for vertebral compression fractures with and without intravertebral clefts. J Bone Joint Surg Br 2006; 88-B: 629-633.
12. Trout AT, Kallmes DF, Kaufmann TJ. New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR Am J Neuroradiol 2006; 27: 217-223.
13. Bono C. Point of view: the honest truth about vertebroplasty. Spine 2006; 31: 1119.
14. Guduguntla M, Subramaniam R. Vertebroplasty: a new treatment for vertebral compression fractures. Aust Family Physician 2006; 35: 304-307.